Topologically associating domains define the impact of de novo promoter variants on autism spectrum disorder risk

Cell Genom. 2024 Feb 14;4(2):100488. doi: 10.1016/j.xgen.2024.100488. Epub 2024 Jan 26.

Abstract

Whole-genome sequencing (WGS) studies of autism spectrum disorder (ASD) have demonstrated the roles of rare promoter de novo variants (DNVs). However, most promoter DNVs in ASD are not located immediately upstream of known ASD genes. In this study analyzing WGS data of 5,044 ASD probands, 4,095 unaffected siblings, and their parents, we show that promoter DNVs within topologically associating domains (TADs) containing ASD genes are significantly and specifically associated with ASD. An analysis considering TADs as functional units identified specific TADs enriched for promoter DNVs in ASD and indicated that common variants in these regions also confer ASD heritability. Experimental validation using human induced pluripotent stem cells (iPSCs) showed that likely deleterious promoter DNVs in ASD can influence multiple genes within the same TAD, resulting in overall dysregulation of ASD-associated genes. These results highlight the importance of TADs and gene-regulatory mechanisms in better understanding the genetic architecture of ASD.

Keywords: ASD; CRISPR-Cas9; CTCF; TAD; de novo variant; enhancer release and retargeting; human iPSC; promoter; regulatory element; whole-genome sequencing.

MeSH terms

  • Autism Spectrum Disorder* / genetics
  • Gene Expression Regulation
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Induced Pluripotent Stem Cells*
  • Whole Genome Sequencing